skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

534 Total results for product and free and sample content found

Medtech Insight

VC Deals Analysis: Could 2017 Smash $6bn Barrier?

By Tina Tan 14 Dec 2017

Five hefty fundraisings pushed the total takings of the first 11 months of 2017 to more than $5.9bn.

Medtech Insight

MTI 100: Medtronic Still Leads, While M&A, Strategic Moves Elevate Others

By Tina Tan 13 Dec 2017

Medtronic has successfully retained the lead in the global medtech market for the second year running.

Medtech Insight

Will Brexit Negotiations Move To Devices Soon?

By Amanda Maxwell 13 Dec 2017

Some progress has finally been made in Brexit talks. It is looking hopeful now that a "hard Brexit," or no-deal Brexit, is unlikely.

Topic Brexit

Pink Sheet

WHO Wants More Transparency From Industry On Falsified Medicines Scourge

By Francesca Bruce 12 Dec 2017

The World Health Organization estimates that one in 10 Medicines in the developing world are falsified.


Sir John Bell: UK Life Science Pact Essential For Post-Brexit Success

By Sten Stovall 12 Dec 2017

Successfully piecing together the agreed life sciences sector deal calls for the UK to embrace high-risk innovation.

Topic Brexit


Discover the top medtech stories from last week - 11 December

11 Dec 2017

Meddevicetracker weekly round up

Topic Medtech weekly roundup


Top Drugs To Watch At ASH 2017: CAR-T, Venetoclax Among Highlights

By Emily Hayes 11 Dec 2017

Highlights of the upcoming American Society of Hematology meeting include updated data for CAR-T therapies.

Topic Cancer


Pharma 'All-Stars' Talk Hot Topics At Forbes Summit

By Jessica Merrill 11 Dec 2017

Some of pharma's biggest names debated the pressing issues impacting industry.

Topic Strategy

Medtech Insight

BFFs With FDA? Repeat Visits From Investigators Can Lead To Poor Device Quality, Recalls, Study Suggests

By Shawn M. Schmitt 08 Dec 2017

When a US FDA investigator is overly familiar with a company and its people, it can lead to a weaker facility inspection.

Topic FDA

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: